Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Longitudinal Effects of Cigarette Smoking and Smoking Cessation on Aortic Wave Reflections, Pulse Wave Velocity, and Carotid Artery Distensibility.

Schmidt KMT, Hansen KM, Johnson AL, Gepner AD, Korcarz CE, Fiore MC, Baker TB, Piper ME, Stein JH.

J Am Heart Assoc. 2019 Dec 17;8(24):e013939. doi: 10.1161/JAHA.119.013939. Epub 2019 Dec 4.

2.

Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use.

Kim N, McCarthy DE, Loh WY, Cook JW, Piper ME, Schlam TR, Baker TB.

Drug Alcohol Depend. 2019 Dec 1;205:107668. doi: 10.1016/j.drugalcdep.2019.107668. Epub 2019 Oct 25.

PMID:
31707266
3.

Progress in Treating Youth Smoking: Imperative, Difficult, Slow.

Piper ME, Mermelstein R, Baker TB.

JAMA Pediatr. 2019 Oct 14. doi: 10.1001/jamapediatrics.2019.3541. [Epub ahead of print] No abstract available.

PMID:
31609441
4.

Corrigendum to: Changes in Use Patterns Over 1 Year Among Smokers and Dual Users of Combustible and Electronic Cigarettes.

Piper ME, Baker TB, Benowitz NL, Jorenby DE.

Nicotine Tob Res. 2019 Oct 14. pii: ntz164. doi: 10.1093/ntr/ntz164. [Epub ahead of print] No abstract available.

PMID:
31609417
5.

Playing Around with Quitting Smoking: A Randomized Pilot Trial of Mobile Games as a Craving Response Strategy.

Schlam TR, Baker TB.

Games Health J. 2019 Sep 19. doi: 10.1089/g4h.2019.0030. [Epub ahead of print]

PMID:
31536384
6.

Liver Paired Exchange: Ready for Prime Time in North America?

Baker TB.

Liver Transpl. 2019 Nov;25(11):1609-1610. doi: 10.1002/lt.25639. No abstract available.

PMID:
31529592
7.

Tobacco Treatment Program Implementation at NCI Cancer Centers: Progress of the NCI Cancer Moonshot-Funded Cancer Center Cessation Initiative.

D'Angelo H, Rolland B, Adsit R, Baker TB, Rosenblum M, Pauk D, Morgan GD, Fiore MC.

Cancer Prev Res (Phila). 2019 Nov;12(11):735-740. doi: 10.1158/1940-6207.CAPR-19-0182. Epub 2019 Sep 3.

PMID:
31481540
8.

Changes in carotid artery structure with smoking cessation.

Mitchell C, Piper ME, Smith SS, Korcarz CE, Fiore MC, Baker TB, Stein JH.

Vasc Med. 2019 Dec;24(6):493-500. doi: 10.1177/1358863X19867762. Epub 2019 Aug 17.

PMID:
31422759
9.

Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes.

Chen J, Loukola A, Gillespie NA, Peterson R, Jia P, Riley B, Maes H, Dick DM, Kendler KS, Damaj MI, Miles MF, Zhao Z, Li MD, Vink JM, Minica CC, Willemsen G, Boomsma DI, Qaiser B, Madden PAF, Korhonen T, Jousilahti P, Hällfors J, Gelernter J, Kranzler HR, Sherva R, Farrer L, Maher B, Vanyukov M, Taylor M, Ware JJ, Munafò MR, Lutz SM, Hokanson JE, Gu F, Landi MT, Caporaso NE, Hancock DB, Gaddis NC, Baker TB, Bierut LJ, Johnson EO, Chenoweth M, Lerman C, Tyndale R, Kaprio J, Chen X.

Nicotine Tob Res. 2019 Jul 11. pii: ntz099. doi: 10.1093/ntr/ntz099. [Epub ahead of print]

PMID:
31294817
10.

Closed-loop electronic referral to SmokefreeTXT for smoking cessation support: a demonstration project in outpatient care.

McCarthy DE, Adsit RT, Zehner ME, Mahr TA, Skora AD, Kim N, Baker TB, Fiore MC.

Transl Behav Med. 2019 Jun 7. pii: ibz072. doi: 10.1093/tbm/ibz072. [Epub ahead of print]

PMID:
31173140
11.

Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment.

Mundt MP, Baker TB, Piper ME, Smith SS, Fraser DL, Fiore MC.

Tob Control. 2019 May 30. pii: tobaccocontrol-2018-054811. doi: 10.1136/tobaccocontrol-2018-054811. [Epub ahead of print]

PMID:
31147478
12.

Changes in Use Patterns OVER ONE YEAR Among Smokers and Dual Users of Combustible and electronic cigarettes.

Piper ME, Baker TB, Benowitz NL, Jorenby DE.

Nicotine Tob Res. 2019 May 6. pii: ntz065. doi: 10.1093/ntr/ntz065. [Epub ahead of print]

PMID:
31058284
13.

Anxiety Sensitivity and Distress Tolerance in Smokers: Relations with Tobacco Dependence, Withdrawal, and Quitting Success.

Schlam TR, Baker TB, Smith SS, Cook JW, Piper ME.

Nicotine Tob Res. 2019 May 6. pii: ntz070. doi: 10.1093/ntr/ntz070. [Epub ahead of print]

PMID:
31056710
14.

Using multidimensional item response theory to evaluate how response styles impact measurement.

Adams DJ, Bolt DM, Deng S, Smith SS, Baker TB.

Br J Math Stat Psychol. 2019 Nov;72(3):466-485. doi: 10.1111/bmsp.12169. Epub 2019 Mar 28.

15.

Variants in the CHRNA5-CHRNA3-CHRNB4 region of chromosome 15 predict gastrointestinal adverse events in the TTURC smoking cessation trial.

Culverhouse RC, Chen LS, Saccone NL, Ma Y, Piper ME, Baker TB, Bierut LJ.

Nicotine Tob Res. 2019 Mar 18. pii: ntz044. doi: 10.1093/ntr/ntz044. [Epub ahead of print]

PMID:
30882151
16.

E-cigarette Dependence Measures in Dual Users: Reliability and Relations with Dependence Criteria and E-Cigarette Cessation.

Piper ME, Baker TB, Benowitz NL, Smith SS, Jorenby DE.

Nicotine Tob Res. 2019 Mar 15. pii: ntz040. doi: 10.1093/ntr/ntz040. [Epub ahead of print]

PMID:
30874804
17.

Effects of motivation phase intervention components on quit attempts in smokers unwilling to quit: A factorial experiment.

Engle JL, Mermelstein R, Baker TB, Smith SS, Schlam TR, Piper ME, Jorenby DE, Collins LM, Cook JW.

Drug Alcohol Depend. 2019 Apr 1;197:149-157. doi: 10.1016/j.drugalcdep.2019.01.011. Epub 2019 Feb 16.

PMID:
30825795
18.

Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.

Mundt MP, Baker TB, Fraser DL, Smith SS, Piper ME, Fiore MC.

Value Health. 2019 Feb;22(2):177-184. doi: 10.1016/j.jval.2018.08.001. Epub 2018 Sep 20.

PMID:
30711062
19.

Triple Smoking Cessation Therapy with Varenicline, Nicotine Patch and Nicotine Lozenge: A Pilot Study to Assess Tolerability, Satisfaction, and End-of-Treatment Quit Rates.

Berg KM, Jorenby DE, Baker TB, Fiore MC.

J Smok Cessat. 2018 Sep;13(3):145-153. doi: 10.1017/jsc.2017.18. Epub 2017 Sep 25.

20.

Use of polygenic risk scores of nicotine metabolism in predicting smoking behaviors.

Chen LS, Hartz SM, Baker TB, Ma Y, L Saccone N, Bierut LJ.

Pharmacogenomics. 2018 Dec;19(18):1383-1394. doi: 10.2217/pgs-2018-0081. Epub 2018 Nov 16.

21.

Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.

Piper ME, Baker TB, Benowitz NL, Kobinsky KH, Jorenby DE.

Nicotine Tob Res. 2019 Aug 19;21(9):1279-1284. doi: 10.1093/ntr/nty231.

PMID:
30365010
22.

E-cigarette Usage Is Associated With Increased Past-12-Month Quit Attempts and Successful Smoking Cessation in Two US Population-Based Surveys.

Johnson L, Ma Y, Fisher SL, Ramsey AT, Chen LS, Hartz SM, Culverhouse RC, Grucza RA, Saccone NL, Baker TB, Bierut LJ.

Nicotine Tob Res. 2019 Sep 19;21(10):1331-1338. doi: 10.1093/ntr/nty211.

23.

A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care.

Piper ME, Cook JW, Schlam TR, Jorenby DE, Smith SS, Collins LM, Mermelstein R, Fraser D, Fiore MC, Baker TB.

Ann Behav Med. 2018 Sep 13;52(10):854-864. doi: 10.1093/abm/kax059.

24.

Liver Transplantation Today: Where We Are Now and Where We Are Going.

Bodzin AS, Baker TB.

Liver Transpl. 2018 Oct;24(10):1470-1475. doi: 10.1002/lt.25320. Review.

25.

Echogenicity of the carotid arterial wall in active smokers.

Mitchell C, Piper ME, Korcarz CE, Hansen K, Weber J, Fiore MC, Baker TB, Stein JH.

J Diagn Med Sonogr. 2018 May;34(3):161-168. doi: 10.1177/8756479317747226. Epub 2017 Dec 19.

26.

Low-Burden Strategies to Promote Smoking Cessation Treatment Among Patients With Serious Mental Illness.

Chen LS, Baker TB, Korpecki JM, Johnson KE, Hook JP, Brownson RC, Bierut LJ.

Psychiatr Serv. 2018 Aug 1;69(8):849-851. doi: 10.1176/appi.ps.201700399. Epub 2018 Jun 1.

27.

Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?

Schlam TR, Cook JW, Baker TB, Hayes-Birchler T, Bolt DM, Smith SS, Fiore MC, Piper ME.

Psychopharmacology (Berl). 2018 Jul;235(7):2065-2075. doi: 10.1007/s00213-018-4903-y. Epub 2018 Apr 25.

28.

Tobacco Use Prevalence and Smoking Cessation Pharmacotherapy Prescription Patterns Among Hospitalized Patients by Medical Specialty.

Srivastava AB, Ramsey AT, McIntosh LD, Bailey TC, Fisher SL, Fox L, Castro M, Ma Y, Baker TB, Chen LS, Bierut LJ.

Nicotine Tob Res. 2019 Apr 17;21(5):631-637. doi: 10.1093/ntr/nty031.

29.

Is the Fagerström test for nicotine dependence invariant across secular trends in smoking? A question for cross-birth cohort analysis of nicotine dependence.

Glasheen C, Johnson EO, Saccone NL, Lutz SM, Baker TB, McNeil DW, Marazita ML, Hokanson JE, Bierut LJ, Hancock DB.

Drug Alcohol Depend. 2018 Apr 1;185:127-132. doi: 10.1016/j.drugalcdep.2017.12.013. Epub 2018 Feb 6.

30.

A randomized controlled trial of financial incentives to low income pregnant women to engage in smoking cessation treatment: Effects on post-birth abstinence.

Baker TB, Fraser DL, Kobinsky K, Adsit R, Smith SS, Khalil L, Alaniz KM, Sullivan TE, Johnson ML, Fiore MC.

J Consult Clin Psychol. 2018 May;86(5):464-473. doi: 10.1037/ccp0000278. Epub 2018 Feb 1.

PMID:
29389142
31.

Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function.

Benjamin AJ, Baker TB, Talamonti MS, Bodzin AS, Schneider AB, Winschester DJ, Roggin KK, Bentrem DJ, Suss NR, Baker MS.

Surgery. 2018 Mar;163(3):582-586. doi: 10.1016/j.surg.2017.12.005. Epub 2018 Jan 20.

PMID:
29370929
32.

The social networks of smokers attempting to quit: An empirically derived and validated classification.

Burgess-Hull AJ, Roberts LJ, Piper ME, Baker TB.

Psychol Addict Behav. 2018 Feb;32(1):64-75. doi: 10.1037/adb0000336. Epub 2017 Dec 18.

33.

A Randomized Trial of Incentives for Smoking Treatment in Medicaid Members.

Fraser DL, Fiore MC, Kobinsky K, Adsit R, Smith SS, Johnson ML, Baker TB.

Am J Prev Med. 2017 Dec;53(6):754-763. doi: 10.1016/j.amepre.2017.08.027. Epub 2017 Nov 2.

34.

Offering smoking treatment to primary care patients in two Wisconsin healthcare systems: Who chooses smoking reduction versus cessation?

Petersen A, Mermelstein R, Berg KM, Baker TB, Smith SS, Jorenby D, Piper ME, Schlam TR, Cook JW.

Prev Med. 2017 Dec;105:332-336. doi: 10.1016/j.ypmed.2017.10.015. Epub 2017 Oct 6.

35.

Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence.

Hancock DB, Guo Y, Reginsson GW, Gaddis NC, Lutz SM, Sherva R, Loukola A, Minica CC, Markunas CA, Han Y, Young KA, Gudbjartsson DF, Gu F, McNeil DW, Qaiser B, Glasheen C, Olson S, Landi MT, Madden PAF, Farrer LA, Vink J, Saccone NL, Neale MC, Kranzler HR, McKay J, Hung RJ, Amos CI, Marazita ML, Boomsma DI, Baker TB, Gelernter J, Kaprio J, Caporaso NE, Thorgeirsson TE, Hokanson JE, Bierut LJ, Stefansson K, Johnson EO.

Mol Psychiatry. 2018 Sep;23(9):1911-1919. doi: 10.1038/mp.2017.193. Epub 2017 Oct 3.

36.

Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience.

Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion RM.

Liver Transpl. 2017 Dec;23(12):1519-1530. doi: 10.1002/lt.24872.

37.

Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function.

Liu JB, Baker TB, Suss NR, Talamonti MS, Roggin KK, Winchester DJ, Baker MS.

Surgery. 2017 Nov;162(5):1032-1039. doi: 10.1016/j.surg.2017.07.017. Epub 2017 Sep 1.

PMID:
28866312
38.

Implementing Clinical Research Using Factorial Designs: A Primer.

Baker TB, Smith SS, Bolt DM, Loh WY, Mermelstein R, Fiore MC, Piper ME, Collins LM.

Behav Ther. 2017 Jul;48(4):567-580. doi: 10.1016/j.beth.2016.12.005. Epub 2017 Jan 7.

39.

Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.

Emond JC, Goodrich NP, Pomposelli JJ, Baker TB, Humar A, Grant DR, Abt P, Friese CE, Fisher RA, Kam I, Sherker AH, Gillespie BW, Merion RM.

Transplantation. 2017 Oct;101(10):2375-2384. doi: 10.1097/TP.0000000000001823.

40.

Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.

Chen LS, Zawertailo L, Piasecki TM, Kaprio J, Foreman M, Elliott HR, David SP, Bergen AW, Baurley JW, Tyndale RF, Baker TB, Bierut LJ, Saccone NL; Genetics and Treatment Workgroup of the Society for Research on Nicotine and Tobacco (SRNT).

Nicotine Tob Res. 2018 Mar 6;20(4):414-424. doi: 10.1093/ntr/ntx097. Review.

41.

Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.

Cook JW, Lanza ST, Chu W, Baker TB, Piper ME.

Nicotine Tob Res. 2017 Jun 1;19(6):703-709. doi: 10.1093/ntr/ntw247.

42.

Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain.

Teitelbaum AM, Murphy SE, Akk G, Baker TB, Germann A, von Weymarn LB, Bierut LJ, Goate A, Kharasch ED, Bloom AJ.

Pharmacogenomics J. 2018 Jan;18(1):136-143. doi: 10.1038/tpj.2016.92. Epub 2017 Mar 14.

43.

Genetic correlation between smoking behaviors and schizophrenia.

Hartz SM, Horton AC, Hancock DB, Baker TB, Caporaso NE, Chen LS, Hokanson JE, Lutz SM, Marazita ML, McNeil DW, Pato CN, Pato MT, Johnson EO, Bierut LJ.

Schizophr Res. 2018 Apr;194:86-90. doi: 10.1016/j.schres.2017.02.022. Epub 2017 Mar 8.

44.

The 2016 Ferno Award Address: Three Things.

Baker TB.

Nicotine Tob Res. 2017 Aug 1;19(8):891-900. doi: 10.1093/ntr/ntx039.

45.

Toward precision smoking cessation treatment I: Moderator results from a factorial experiment.

Piper ME, Schlam TR, Cook JW, Smith SS, Bolt DM, Loh WY, Mermelstein R, Collins LM, Fiore MC, Baker TB.

Drug Alcohol Depend. 2017 Feb 1;171:59-65. doi: 10.1016/j.drugalcdep.2016.11.025. Epub 2016 Nov 25.

46.

Toward precision smoking cessation treatment II: Proximal effects of smoking cessation intervention components on putative mechanisms of action.

Piper ME, Cook JW, Schlam TR, Smith SS, Bolt DM, Collins LM, Mermelstein R, Fiore MC, Baker TB.

Drug Alcohol Depend. 2017 Feb 1;171:50-58. doi: 10.1016/j.drugalcdep.2016.11.027. Epub 2016 Nov 24.

47.

Living liver donation, donor safety, and social media: Preparing for a new frontier.

Baker TB.

Liver Transpl. 2017 Feb;23(2):131-132. doi: 10.1002/lt.24698. No abstract available.

48.

Smoking-induced affect modulation in nonwithdrawn smokers with posttraumatic stress disorder, depression, and in those with no psychiatric disorder.

Cook JW, Baker TB, Beckham JC, McFall M.

J Abnorm Psychol. 2017 Feb;126(2):184-198. doi: 10.1037/abn0000247. Epub 2016 Dec 22.

49.

Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk.

King CC, Piper ME, Gepner AD, Fiore MC, Baker TB, Stein JH.

Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):374-379. doi: 10.1161/ATVBAHA.116.308728. Epub 2016 Dec 8.

50.

Nicotine levels, withdrawal symptoms, and smoking reduction success in real world use: A comparison of cigarette smokers and dual users of both cigarettes and E-cigarettes.

Jorenby DE, Smith SS, Fiore MC, Baker TB.

Drug Alcohol Depend. 2017 Jan 1;170:93-101. doi: 10.1016/j.drugalcdep.2016.10.041. Epub 2016 Nov 9.

Supplemental Content

Loading ...
Support Center